Section | Headnote |
---|---|
PHARMACY PRACTICE ACT | |
151.01 | DEFINITIONS. |
151.02 | STATE BOARD OF PHARMACY. |
151.03 | MEMBERSHIP. |
151.04 | RECOMMENDED NAMES. |
151.05 | ELECTION OF OFFICERS. |
151.06 | POWERS AND DUTIES. |
151.061 | UNFAIR PRICE DISCRIMINATION. |
151.065 | FEE AMOUNTS. |
151.066 | OPIATE PRODUCT REGISTRATION FEE. |
151.07 | MEETINGS; EXAMINATION FEE. |
151.071 | DISCIPLINARY ACTION. |
151.072 | REPORTING OBLIGATIONS. |
151.073 | IMMUNITY. |
151.074 | LICENSEE OR REGISTRANT COOPERATION. |
151.075 | DISCIPLINARY RECORD ON JUDICIAL REVIEW. |
151.08 | [Repealed, 1975 c 136 s 77] |
151.09 | [Repealed, 1976 c 222 s 209] |
151.095 | INACTIVE STATUS LICENSE. |
151.10 | QUALIFICATIONS OF APPLICANTS. |
151.101 | INTERNSHIP. |
151.102 | PHARMACY TECHNICIAN. |
151.11 | [Repealed, 1988 c 550 s 20] |
151.12 | RECIPROCITY; LICENSURE. |
151.13 | RENEWAL FEE; CONTINUING EDUCATION. |
151.14 | REINSTATEMENTS. |
151.15 | COMPOUNDING DRUGS UNLAWFUL UNDER CERTAIN CONDITIONS. |
151.16 | VIOLATION A GROSS MISDEMEANOR. |
151.17 | UNLAWFUL USE OF "PHARMACIST." |
151.18 | UNLAWFUL TO USE MISLEADING NAME. |
151.19 | REGISTRATION; FEES. |
151.191 | LICENSING MEDICAL GAS FACILITIES; FEES; PROHIBITIONS. |
151.20 | [Repealed, 1969 c 933 s 22] |
151.21 | SUBSTITUTION. |
151.211 | RECORDS OF PRESCRIPTIONS. |
151.212 | LABEL OF PRESCRIPTION DRUG CONTAINERS. |
151.213 | COPIES OF PRESCRIPTIONS. |
151.214 | PAYMENT DISCLOSURE. |
151.215 | CERTIFICATION. |
151.22 | LIABILITY FOR QUALITY OF DRUGS. |
151.23 | POISONS MUST BE LABELED. |
151.24 | SALE OF POISONS MUST BE RECORDED. |
151.25 | [Repealed, 2013 c 108 art 10 s 13] |
151.252 | LICENSING OF DRUG MANUFACTURERS; FEES; PROHIBITIONS. |
151.253 | COMPOUNDING. |
151.26 | EXCEPTIONS. |
151.27 | EXPENSES. |
151.28 | [Repealed, 1988 c 550 s 20] |
151.29 | VIOLATION A MISDEMEANOR. |
151.30 | COUNTY ATTORNEY TO PROSECUTE. |
151.301 | REPORTS TO COMMISSIONER OF HEALTH. |
151.302 | IMMUNITY. |
151.31 | [Repealed, 1988 c 550 s 20] |
151.32 | CITATION. |
151.33 | CARELESS DISTRIBUTION OF DRUGS. |
151.335 | DELIVERY THROUGH COMMON CARRIER; COMPLIANCE WITH TEMPERATURE REQUIREMENTS. |
151.34 | PROHIBITED ACTS. |
151.35 | DRUGS, ADULTERATION. |
151.36 | DRUGS, MISBRANDING. |
151.361 | MANUFACTURER DISCLOSURE. |
151.37 | LEGEND DRUGS; WHO MAY PRESCRIBE, POSSESS. |
151.375 | INVESTIGATIONAL DRUG USE. |
151.38 | EMBARGOES. |
151.39 | DISTRESSED DRUGS. |
151.40 | POSSESSION AND SALE OF HYPODERMIC SYRINGES AND NEEDLES. |
151.41 | [Repealed, 1981 c 323 s 4; 1983 c 312 art 1 s 27] |
LONG-TERM CARE RESIDENT ACCESS TO PHARMACEUTICALS ACT | |
151.415 | LONG-TERM CARE RESIDENT ACCESS TO PHARMACEUTICALS ACT. |
WHOLESALE DRUG DISTRIBUTION LICENSING | |
151.42 | MS 2018 [Repealed, 1Sp2019 c 9 art 10 s 53] |
151.43 | SCOPE. |
151.44 | MS 2018 [Repealed, 1Sp2019 c 9 art 10 s 53] |
151.441 | DEFINITIONS. |
151.45 | [Repealed, 2013 c 108 art 10 s 13] |
151.46 | PROHIBITED DRUG PURCHASES OR RECEIPT. |
151.461 | GIFTS TO PRACTITIONERS PROHIBITED. |
151.47 | WHOLESALE DRUG DISTRIBUTOR LICENSING REQUIREMENTS. |
151.471 | THIRD-PARTY LOGISTICS PROVIDER REQUIREMENTS. |
151.48 | [Repealed, 2013 c 108 art 10 s 13] |
151.49 | MS 2018 [Repealed, 1Sp2019 c 9 art 10 s 53] |
151.50 | MS 2018 [Repealed, 1Sp2019 c 9 art 10 s 53] |
151.51 | MS 2018 [Repealed, 1Sp2019 c 9 art 10 s 53] |
CANCER DRUG REPOSITORY PROGRAM | |
151.55 | MS 2018 [Repealed, 1Sp2019 c 9 art 10 s 53] |
151.555 | MEDICATION REPOSITORY PROGRAM. |
RETURN OF UNUSED DRUGS | |
151.56 | COUNTY RETURN OF UNUSED DRUGS OR MEDICAL DEVICES. |
AUTOMATED DRUG DISTRIBUTION | |
151.58 | AUTOMATED DRUG DISTRIBUTION SYSTEMS. |
151.60 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.61 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.62 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.63 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.64 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.65 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.66 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.67 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.68 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.69 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.70 | MS 2018 [Repealed, 2019 c 39 s 23] |
MAXIMUM ALLOWABLE COST PRICING | |
151.71 | MS 2018 [Repealed, 2019 c 39 s 23] |
151.72 | SALE OF CERTAIN CANNABINOID PRODUCTS. |
151.74 | INSULIN SAFETY NET PROGRAM. |
Official Publication of the State of Minnesota
Revisor of Statutes